Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Jeff Huber, Joel McComb, Greg Lucier

Premium

Illumina has appointed Jeff Huber to its board of directors. Huber is senior vice president at Google and led development for Google Maps, Google Apps, and Google Ads. Previously, he was vice president of architecture and systems development at eBay and senior vice president of engineering at [email protected] He is also a member of the board of directors and audit committee of Electronic Arts.


Bio-Rad Laboratories has appointed Joel McComb to its board of directors.

Since mid-2010 McComb has founded three technology companies in the life science and diagnostics markets under the umbrella of Point Break Capital. The technologies focus on RNA expression, cancer profiling, and pathology.

McComb previously served as vice president and general manager of Illumina's Life Science business unit, where he was responsible for leading global product development, business strategy, and overall operations.

Prior to joining Illumina, McComb held two high-level positions at General Electric, serving as president of GE Healthcare Life Sciences-Discovery Systems and president of GE Healthcare Interventional Medicine. McComb has also served as president and CEO of Innovadyne Technologies, and held a series of executive, product development, business, and sales positions at Beckman Coulter.


Former Life Technologies leader Greg Lucier will work with Organovo Holdings, a 3-D biology company, as a corporate advisor. He will advise the company on various corporate issues.

Lucier was chairman and CEO of Life Technologies for 11 years before it was acquired by Thermo Fisher Scientific in 2014, and he oversaw the merger of Applied Biosystems and Invitrogen that created Life Technologies in 2008. He currently serves on the board of NuVasive Corporation, RainTree Oncology Services, CareFusion, and is board chairman for the Sanford Burnham Medical Research Institute

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.